Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.680
-0.370 (-9.14%)
Sep 23, 2026, 2:45 PM EDT - Market open
Recursion Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Recursion Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $7.22. The average 1-year stock price forecast is 96.20% higher than the current stock price, while the lowest is $4.00 (+8.70%) and the highest is $10 (+171.74%).
Price Target: $7.22 (+96.20%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Aug 17, 2026.
Analyst Ratings
The average analyst rating for Recursion Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 5 | 5 | 5 | 5 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Sep 21, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 15, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $5.5 → $5.3 | Hold | Reiterates | $5.5 → $5.3 | +44.02% | Aug 17, 2026 |
| TD Cowen | TD Cowen | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 6, 2026 |
| Needham | Needham | Buy Maintains $8 | Buy | Maintains | $8 | +117.39% | Aug 5, 2026 |
Financial Forecast
Revenue This Year
38.81M
from 74.68M
Decreased by -48.04%
Revenue Next Year
52.38M
from 38.81M
Increased by 34.96%
EPS This Year
-0.93
from -1.44
EPS Next Year
-0.90
from -0.93
EPS and Forward PE are based on non-GAAP adjusted numbers.